Biological challenges and technological opportunities for respiratory syncytial virus vaccine development-Reference-Cited by-同舟云学术

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Published:2010-12-28 Issue:1 Volume:239 Page:149-166
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:

Author:

Graham Barney S.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-065X.2010.00972.x/fullpdf

Reference135 articles.

1. Recovery of cytopathogenic agent from chimpanzees with coryza;Blount;Proc Soc Exp Biol Med,1956

2. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children;Chanock;Am J Hyg,1957

3. Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks;Hendry;J Infect Dis,1986

4. Bronchiolitis-associated hospitalizations among US children, 1980-1996;Shay;JAMA,1999

5. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis;eBioMedicine;2024-09

2. Hybrid Predictive Machine Learning Model for the Prediction of Immunodominant Peptides of Respiratory Syncytial Virus;Bioengineering;2024-08-05

3. Putative new combination vaccine candidates identified by reverse vaccinology and genomic approaches to control enteric pathogens;BMC Immunology;2024-07-22

4. Next-Generation Vaccine Development with Nanomaterials: Recent Advances, Possibilities, and Challenges;Annual Review of Biomedical Engineering;2024-07-03

5. Immunoprophylaxis of Respiratory Syncytial Virus Infection: Recent Updates;Indian Journal of Respiratory Care;2024-04-06